H.C. Wainwright Remains a Buy on ATAI Life Sciences (ATAI)
ATAI Life Sciences Finalizes Separation With CBO
Express News | Reported Earlier: 'Texas Lawmakers Take Up Bills To Expedite Access To Psychedelic Therapy' - Marijuana Moment
Atai Life Sciences Started at Positive by Berenberg
$ATAI Stock Is up 14% Today. Here's What We See in Our Data.
World's First AI Stem Cell-engineered Cognitive AI Platform Launched by Irish-based Partsol
Atai Life Sciences CEO Discusses Major Data Readouts Expected Through 2025 - ICYMI | NASDAQ:ATAI, ETR:9VC
Insider Purchase: 10% Owner at $ATAI Buys 1,800,000 Shares
Atai Life Sciences Director Angermayer Buys $2.52 Million in Shares
Biotech's ATAI Life Sciences Joins Roster of Firms With Bitcoin Treasury Strategies
Psychedelic: Atai Life Sciences, NRx Report Quarterly Results
H.C. Wainwright Maintains ATAI Life Sciences(ATAI.US) With Buy Rating, Maintains Target Price $10
HC Wainwright & Co. Reiterates Buy on ATAI Life Sciences, Maintains $10 Price Target
ATAI Life Sciences Analyst Ratings
TD Cowen Maintains ATAI Life Sciences(ATAI.US) With Buy Rating
ATAI Life Sciences | 10-K: FY2024 Annual Report
Atai Life Sciences Prepares for Data Readouts From Key Clinical Trials, Extends Operational Runway | NASDAQ:ATAI, ETR:9VC
ATAI Life Sciences | 8-K: atai Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights
Express News | ATAI Life Sciences Q4 EPS $(0.24) Misses $(0.15) Estimate
ATAI Life Sciences 4Q Net $39M >ATAI